Overview

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
-To compare the single dose bioavailability of Kali and BTG
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Cetero Research, San Antonio
Treatments:
Oxandrolone